Mismatch Repair (MMR) Gene Alteration and BRAF V600E Mutation Are Potential Predictive Biomarkers of Immune Checkpoint Inhibitors in MMR-Deficient Colorectal Cancer.
Ibrahim Halil SahinSubir GoyalYoanna PumpalovaMohamad B SonbolSatya DasSigurdis HaraldsdottirDaniel AhnKristen K CiomborZhengjia ChenAmber DraperJordan BerlinTanios Bekaii-SaabGregory B LesinskiBassel F El-RayesChristina WuPublished in: The oncologist (2021)
The results of this study reveal clinically important biomarkers that potentially predict immune checkpoint inhibitor response in patients with mismatch repair-deficient colorectal cancer.